Upcoming Presentations
UBC scientists participate in scientific and clinical meetings around the world. To learn more about a presentation, please contact the UBC scientist directly or call 301-654-9729.
SCOPE Summit for Clinical Ops Executives
Feb 7 - Feb 9 2012
Miami, FL, USA
www.scopesummit.com/
PRE-CONFERENCE SHORT COURSE
Social Media and Mobile Technology in Supporting Patients in Studies and Registries
Abbe Steel, Vice President, Patient & Physician Services, United BioSource Corporation
SESSIONS
Customized Targeting and Profiling: Finding the Right Patient in the Right Way
Nancy Mulligan, Director Patient & Physician Services, United BioSource Corporation
Is There Patient Recruitment in a Post-Marketing Study?
Tess Dorrier, Associate Director, Patient & Physician Services, United BioSource Corporation
TRIAL SPONSOR PANEL
Find the Ideal Site
Moderator: Abbe Steel, Vice President, Patient & Physician Services, United BioSource Corp.
Panelists: Joseph Kim, MBA, Clinical Operations Director, Shire; Nye Pelton, (COPM) Clinical Operations Portfolio Management, USMD, Eli Lilly; Sudeesh Tantry, PhD, Associate Director, Clinical Research, Teva Branded Pharmaceutical Products R&D, Inc.ROUNDTABLES
TABLE 18: Keeping Post Marketing Studies Top of Mind
Moderator: Tess Dorrier, Associate Director, Patient & Physician Services, United BioSource Corp.TABLE 32: Recruiting using a Social Marketing Approach
Moderator: Nancy Mulligan, Director, Patient & Physician Services, United BioSource Corp.13th Annual CTS Europe
Feb 21 - Feb 22 2012
London, UK
www.arena-international.com/ctseurope
SPEAKER
Optimising the Accuracy and Efficiency of Demand Forecasting Through Effective Use of Your IVRS
Kimberly Sierk, Senior Design Engineer, BracketISCTM 8th Annual Scientific Meeting
Feb 21 - Feb 23 2012
Washington, DC, USA
www.cvent.com/events/8th-annual-scientific-meeting-plus-forum/event-summary-bd23243ecc7d4ffba95dde9551922b4d.aspx
SESSION SPEAKER
Defining Clinically Meaningful Effect for the Design and Interpretation of RCTs - Payers Perspectives
Robert S. Epstein, MD, MS, Senior Vice President and Chief Medical Officer, Medco Health Solutions and President, United BioSource Corporation
WORKSHOPS
Negative Symptoms
Co-Chairs: Stephen Marder, MD, Director, Dept. of Veterans Affairs and Prof. Psychiatry, UCLA; David Daniel, MD, Senior Vice President, Chief Medical Director, Bracket
Suicidal Ideation and Behavior Assessment
Co-Chairs: Adam Butler, Associate VP, Marketing & Customer Services, Bracket; Michelle Stewart, PhD, Director, Pfizer
POSTER PRESENTATIONS
Assessing Cognitive Function Via The Internet
Wesnes K
Assessing Longitudinal Changes In Cognitive Function In The Elderly
Wesnes K
Low-Contrast Visual Acuity Correlates with Cognitive Performance in Relapsing-Remitting and Secondary-Progressive Multiple Sclerosis
Feaster T
Novel Method for Maintaining Ratings Quality in Global Schizophrenia Clinical Trials
Daniel D, Kott A
Ratings Variability of UPDRS Part III Sub-items in Multinational Parkinson’s Disease Clinical Trials
Swartz J, Wesnes KCBI's 8th Annual Summit on Late Phase Research
Feb 28 - Feb 29 2012
Amsterdam, Netherlands
www.cbinet.com/conference/pc12011
SPEAKER
Transparency of Benefit-Risk Analysis in Drug Development - An EMA Initiative
Ruben Ayzin Rosoky, MD, PhD, Safety Physician, United BioSource Corporation
SUFU Society for Urodynamics and Female Urology 2010 Winter Meeting
Feb 28 - Mar 3 2012
New Orleans, LA, USA
www.sufuorg.com/meetings/2012/default.aspx
PODIUM PRESENTATIONS
Short-Term Outcomes of Vaginal Mesh Placement Among Female Medicare Beneficiaries
Anger J, Eilber K, Khan A, Histed S, Wu N, Pashos C, Clemens JQ
Predictors of Outcomes of Prolapse Surgery Among Female Medicare Beneficiaries: The Role of Apical Support
Histed S, Khan A, Alperin M, Wu N, Pashos C, Clemens JQ, Anger J
Cost-Effectiveness of Sacral Neuromodulation and Botulinum Toxin-A for Patients with Refractory Idiopathic Overactive Bladder
Clemens JQ, Anger JT, Ganz ML, Denevich S, Shah D, Carlson AM, Wittek MR, Pashos CL
Comparative Outcomes of Open Versus Laparoscopic Sacrocolpopexy Among Female Medicare Beneficiaries.
Prize Essay Winner
Anger J, Khan A, Alperin M, Wu N, Clemens JQ, Dubina E, Pashos C
POSTER PRESENTATIONS
Patterns of Pessary Care Among Medicare Beneficiaries with Pelvic Organ Prolapse
Khan A, Alperin M, Dubina E, Tarnay C, Wu N, Pashos C, Anger J
Trends in Prolapse Management Among Medicare Beneficiaries in the New Millennium
Khan A, Eilber K, Alperin M, Wu N, Clemens JQ, Pashos C, Anger J
Surgeon Impact on Prolapse Surgery Outcomes
Eilber K, Khan A, Alperin M, Clemens JQ, Wu N, Pashos C, Anger JPartnerships in Clinical Trials
Mar 4 - Mar 7 2012
Orlando, FL, USA
www.iirusa.com/cropartners/welcome-to-CROs.xml
SESSION PRESENTATION
Strategic Study Designs that Consider Complex Regulatory and Payer Requirements to Drive Efficiencies and Ensure Successful Product Commercialization
Presenters: Krista A. Payne, MEd, Senior Director & Senior Research Scientist, United BioSource Corporation; Mary Rose Keller, Vice President of Clinical Operations, SangartAPhA2012 Annual Meeting & Exposition
Mar 9 - Mar 12 2012
New Orleans, LA, USA
www.aphameeting.org/
POSTER PRESENTATION
Discontinuation of Warfarin Treatment for Venous Thromboembolism and its Association with Recurrent Events in High-Risk Patients
Chen SY, Wu N, Gulseth M, LaMori J, Bookhart B, Boulanger L, Fields L, Schein JCBI's Forum on Real-World Data Analytics and Outcomes
Mar 14 - Mar 15 2012
Philadelphia, PA, USA
www.cbinet.com/conference/pc12002
SPEAKER
Increase Efficiency When Gathering Real-World Data through Strategic Registry Designs and Operational Infrastructures
Krista A. Payne, Executive Director & Senior Research Scientist, United BioSource CorporationComparative Effectiveness: A Real-World User's Guide
Mar 14 - Mar 15 2012
Washington, DC, USA
meetings.diahome.org/12027/#overview
SESSION SPEAKER
Comparative Effectiveness Policy Background, Perspectives and Issues
Bryan R. Luce, PhD, MBA, Senior Vice President, Science Policy, United BioSource CorporationPharma Pricing & Market Access Outlook Europe
Mar 20 - Mar 23 2012
London, UK
www.healthnetworkcommunications.com/conference/pharma-pricing-market-access/
SPEAKER
Get Over It: Embrace Payer Expectations by Introducing Them Early in Product Development
Raf De Wilde, PhD, Associate Vice President, Global Market Access Consulting, United BioSource CorporationLate Phase Drug Development World Americas
Mar 20 - Mar 23 2012
Boston, MA, USA
www.healthnetworkcommunications.com/2012/late-phase-drug-development/
SPEAKER
Getting the Right Evidence From Your Late Stage Activities: The Importance of Planning Ahead
Teresa (Terry) K. Wilcox, RPh, PhD, Senior Research Scientist, Evidence Generation Strategy Practice Lead, United BioSource CorporationACC.12 American College of Cardiology 61st Annual Scientific Session & Expo
Mar 24 - Mar 27 2012
Chicago, IL, USA
accscientificsession.cardiosource.org/ACC12.aspx
POSTER PRESENTATION
Incidence Rates of Death and Major Cardiovascular Events among Hospitalized Patients with Acute Coronary Syndrome – An Analysis of a National Representative Medicare Population
Crivera C, Chen SY, Stokes M, Boulanger L, Schein JDIA 24th Annual EuroMeeting
Mar 26 - Mar 28 2012
Copenhagen, Denmark
www.diahome.org/diahome/FlagshipMeetings/home.aspx?meetingid=25205
SESSION 0403
Tues., 27 March 2012, 14:00 - 15:30
Update on How Agencies and Patients Assess the Therapeutic Value and Therapeutic Added Value of Medicines: How Does this Impact the HTA Processes?
Theme Leader and Session Chair: Ingela Wiklund, PhD, Senior Research Leader, United BioSource Corp.
SESSION 0407
Wed., 28 March 2012, 14:00 - 15:30
A Case Study - How to Make the Most of Your Observational Data
Speaker: Krista Payne, MEd, Senior Director of Healthcare Data Capture, Senior Research Scientist, United BioSource Corp.
SESSION 1008
Wed., 28 March 2012, 16:00 - 17:30
The Perfect e-Menu (Meeting the Needs of Lifecycle Research)
Speaker: Rob Thwaites, MA, MCom, Vice President Health Economics, United BioSource Corp.World Drug Safety Congress Americas
Apr 17 - Apr 20 2012
Boston, MA, USA
www.healthnetworkcommunications.com/2012/world-drug-safety-congress/
SPEAKER
Benefit Risk Analysis: Responding to the New Regulatory Framework
Jonathan Morris, MD, Vice President, Evidence Development, United BioSource CorporationAMCP 24th Annual Meeting & Expo
Apr 18 - Apr 20 2012
San Francisco, CA, USA
www.amcpmeetings.org/
POSTER PRESENTATIONS
Compliance With Warfarin Treatment for Venous Thromboembolism in High-Risk Patients and Its Association With Recurrent Events
Chen, SY, Wu N, Gulseth M, Bookhart B, Boulanger L, Fields LE, Schein J, LaMori J
Impact of a Tier Reduction on Statin Adherence
Chen, S, Shah SN, Raskind J, Lee Y, Boulanger L, Barus T, Mardekian J, Kuznik A2012 Eighth Annual Armada Specialty Pharmacy Summit
May 1 - May 4 2012
Las Vegas, NV, USA
www.armadasummit.com/index.html
SESSION SPEAKER
Tues., May 1, 2012, 4:30 - 5:30 p.m.
REMS 2012 and Beyond: Ensuring Your Risk Evaluation and Mitigation Strategy (REMS) Optimizes Appropriate Patient Support
Annette Stemhagen, DrPH, FISPE, Senior Vice President, Safety, Epidemiology, Registries & Risk Management, United BioSource Corp.ARVO 2012
May 6 - May 10 2012
Fort Lauderdale, FL, USA
www.arvo.org/sites/annual-meeting/2012
POSTER PRESENTATION
Vision-Related Symptoms And Functional Impairments In Patients With Geographic Atrophy (GA): Findings From A Qualitative Study
Wang F, Hareendran A, Sunness JS, Fletcher DCCBI's 9th Forum on Patient Reported Outcomes (PRO)
May 7 - May 8 2012
Philadelphia, PA, USA
www.cbinet.com/conference/pc12141
SPEAKERS
Mixed Modes and the Impact on PRO Data Collection
Sonya Eremenco, ePRO Manager, United BioSource Corporation
Rasch Analysis to Ensure Quality Questions
Wen-Hung Chen, PhD, Research Scientist, Outcomes Research, United BioSource CorporationATS 2012
May 18 - May 23 2012
San Francisco, CA, USA
conference.thoracic.org/2012/index.php
POSTER PRESENTATIONS
Conceptualization Of Symptoms And Symptom Impacts Among Adults With Inadequately Controlled Moderate-Severe Asthma
McLaurin KK, Pokrzywinski R, O'Quinn S, Xu X, Hareendran A
COPD Patients’ Experience Of Early Morning Symptoms: Results From Qualitative Research
Mocarski M, Houghton K, Palsgrove A, Hareendran A, Schaefer M, Carson R, Setyawan J, Make BJDIA 2012 48th Annual Meeting
Jun 24 - Jun 28 2012
Philadelphia, PA, USA
www.diahome.org/DIAHome/Home.aspx
Mon., June 25, 1:30 - 3:30 p.m.
SESSION SPEAKER
A Writer's Perspective on Safety Documents Before the Marketing Application
Michael D. Hoffman, MS, Senior Director, Medical Writing and Regulatory Operations, United BioSource Corporation
Mon., June 25, 3:30 - 5:00 p.m.
SESSION SPEAKERS
PRO Consortia: A Success Story
Nancy Kline Leidy, PhD, Senior Vice President, Scientific Affairs, United BioSource Corporation
Epidemiologic Studies as Part of Risk Management Strategies for Marketed Products
Catherine Sigler, DVM, MPH, Senior Epidemiologist, United BioSource Corporation
Tues., June 26, 10:00 - 11:30 a.m.
SESSION PANELIST
Collaborative Research with Members of the Payer Community
Robert S. Epstein, MD, MS, Senior Vice President and Chief Medical Officer, Medco Health Solutions and President, United BioSource Corporation
Tues., June 26, 12:00 - 1:30 p.m.
SESSION PANELIST
Challenges of Precision Medicine: Diagnostics, Reimbursement, Partnership Co-Development
Robert S. Epstein, MD, MS, Senior Vice President and Chief Medical Officer, Medco Health Solutions and President, United BioSource Corporation
Wed., June 27, 10:00 - 11:30 a.m.
SESSION CHAIR AND SPEAKER
Natural History Studies for Rare Diseases and Orphan Conditions
Annette Stemhagen, DrPH, FISPE, Senior Vice President, Safety, Epidemiology, Registries and Risk Management, United BioSource Corporation
Wed., June 27, 1:30 - 3:00 p.m.
SESSION CHAIR
Data Sources for Monitoring Usage of Drug Products and How to Use these Sources to Support Safety and REMS Evaluations
Juliane Mills, Project Manager, SERRM, United BioSource Corporation9th Annual Meeting HTAi Bilbao 2012
Jun 25 - Jun 27 2012
Bilbao, Spain
www.htai2012.org/
PANEL SESSION
How to Optimally Assess the Relative Value of Disease Modifying Treatments in Multiple Sclerosis
Panel Coordinator: J. Jaime Caro, MDCM, FRCPC, FACP, Senior Vice President, Research, United BioSource Corporation
ORAL PRESENTATION
Innovation, Innovation Everywhere - What is Innovation?
Floortje van Nooten, MSc, PharmD, Research Scientist, United BioSource Corporation; J. Jaime Caro, MDCM, FRCPC, FACP, Senior Vice President, Research, United BioSource Corporation